albertsons companies - ACI

ACI

Close Chg Chg %
19.07 0.28 1.44%

Open Market

19.35

+0.28 (1.44%)

Volume: 319.06K

Last Updated:

Nov 22, 2024, 12:20 PM EDT

Company Overview: albertsons companies - ACI

ACI Key Data

Open

$19.08

Day Range

19.08 - 19.35

52 Week Range

17.80 - 23.42

Market Cap

$11.04B

Shares Outstanding

579.35M

Public Float

420.02M

Beta

0.33

Rev. Per Employee

N/A

P/E Ratio

11.11

EPS

$1.73

Yield

251.84%

Dividend

$0.12

EX-DIVIDEND DATE

Oct 28, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

2.98M

 

ACI Performance

1 Week
 
0.95%
 
1 Month
 
3.53%
 
3 Months
 
-8.93%
 
1 Year
 
-11.22%
 
5 Years
 
N/A
 

ACI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 18
Full Ratings ➔

About albertsons companies - ACI

Albertsons Cos., Inc. engages in the operation of food and drug retail stores. It offers grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. The company was founded by Joe Albertson on July 21, 1939 and is headquartered in Boise, ID.

ACI At a Glance

Albertsons Cos., Inc.
250 Parkcenter Boulevard
Boise, Idaho 83706
Phone 1-208-395-6200 Revenue 79.24B
Industry Food Retail Net Income 1.30B
Sector Retail Trade 2024 Sales Growth 2.045%
Fiscal Year-end 02 / 2025 Employees 285,000
View SEC Filings

ACI Valuation

P/E Current 11.147
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 9.621
Price to Sales Ratio 0.157
Price to Book Ratio 4.495
Price to Cash Flow Ratio 4.685
Enterprise Value to EBITDA 5.549
Enterprise Value to Sales 0.334
Total Debt to Enterprise Value 0.538

ACI Efficiency

Revenue/Employee 278,027.018
Income Per Employee 4,547.368
Receivables Turnover 109.384
Total Asset Turnover 2.754

ACI Liquidity

Current Ratio 0.843
Quick Ratio 0.18
Cash Ratio 0.028

ACI Profitability

Gross Margin 25.788
Operating Margin 2.939
Pretax Margin 2.005
Net Margin 1.636
Return on Assets 4.504
Return on Equity 59.474
Return on Total Capital 7.629
Return on Invested Capital 8.388

ACI Capital Structure

Total Debt to Total Equity 518.268
Total Debt to Total Capital 83.826
Total Debt to Total Assets 49.451
Long-Term Debt to Equity 483.225
Long-Term Debt to Total Capital 78.158
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Albertsons Companies - ACI

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
69.69B 71.89B 77.65B 79.24B
Sales Growth
+11.58% +3.15% +8.02% +2.05%
Cost of Goods Sold (COGS) incl D&A
50.64B 52.70B 57.54B 58.80B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
2.12B 2.31B 2.46B 2.44B
Depreciation
1.96B 2.08B 2.14B 2.05B
Amortization of Intangibles
156.60M 187.20M 253.60M 312.70M
COGS Growth
+12.89% +4.06% +9.19% +2.19%
Gross Income
19.05B 19.19B 20.11B 20.43B
Gross Income Growth
+8.26% +0.73% +4.80% +1.63%
Gross Profit Margin
+27.33% +26.69% +25.89% +25.79%
2021 2022 2023 2024 5-year trend
SG&A Expense
17.34B 16.66B 17.82B 18.10B
Research & Development
- - - -
-
Other SG&A
17.34B 16.66B 17.82B 18.10B
SGA Growth
+4.56% -3.90% +6.96% +1.60%
Other Operating Expense
- - - -
-
Unusual Expense
217.30M 107.30M 118.20M 215.80M
EBIT after Unusual Expense
1.49B 2.42B 2.17B 2.11B
Non Operating Income/Expense
173.50M 163.20M 172.10M (15.80M)
Non-Operating Interest Income
- - - 15.90M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
538.20M 481.90M 404.60M 508.00M
Interest Expense Growth
-22.89% -10.46% -16.04% +25.56%
Gross Interest Expense
538.20M 481.90M 404.60M 508.00M
Interest Capitalized
- - - -
-
Pretax Income
1.13B 2.10B 1.94B 1.59B
Pretax Income Growth
+88.37% +86.01% -7.81% -17.90%
Pretax Margin
+1.62% +2.92% +2.49% +2.01%
Income Tax
278.50M 479.90M 422.00M 293.00M
Income Tax - Current - Domestic
391.50M 260.30M 408.60M 404.60M
Income Tax - Current - Foreign
(700.00K) 600.00K 500.00K 1.00M
Income Tax - Deferred - Domestic
(119.80M) 210.70M 3.50M (51.40M)
Income Tax - Deferred - Foreign
7.50M 8.30M 9.40M (61.20M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
850.20M 1.62B 1.51B 1.30B
Minority Interest Expense
- - - -
-
Net Income
850.20M 1.62B 1.51B 1.30B
Net Income Growth
+82.29% +90.50% -6.55% -14.37%
Net Margin Growth
+1.22% +2.25% +1.95% +1.64%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
850.20M 1.62B 1.51B 1.30B
Preferred Dividends
86.00M 335.60M 303.20M 1.00M
Net Income Available to Common
764.20M 1.28B 1.21B 1.29B
EPS (Basic)
1.6414 2.7342 2.2879 2.2506
EPS (Basic) Growth
+68.59% +66.58% -16.32% -1.63%
Basic Shares Outstanding
465.57M 469.60M 529.00M 575.40M
EPS (Diluted)
1.6414 2.7014 2.2665 2.2285
EPS (Diluted) Growth
+68.59% +64.58% -16.10% -1.68%
Diluted Shares Outstanding
465.57M 475.30M 534.00M 581.10M
EBITDA
3.83B 4.83B 4.75B 4.77B
EBITDA Growth
+16.96% +26.16% -1.75% +0.56%
EBITDA Margin
+5.49% +6.72% +6.11% +6.02%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 23.712
Number of Ratings 18 Current Quarters Estimate 0.658
FY Report Date 11 / 2024 Current Year's Estimate 2.271
Last Quarter’s Earnings 0.51 Median PE on CY Estimate N/A
Year Ago Earnings 2.88 Next Fiscal Year Estimate 2.297
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 18 18 18 18
Mean Estimate 0.66 0.44 2.27 2.30
High Estimates 0.72 0.54 2.35 2.65
Low Estimate 0.62 0.37 2.18 1.94
Coefficient of Variance 4.09 8.85 2.29 6.96

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 7 7 4
OVERWEIGHT 1 1 1
HOLD 10 11 12
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Albertsons Companies - ACI

Date Name Shares Transaction Value
Jul 17, 2024 Jennifer Saenz EVP Pharmacy & eCommerce 146,756 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $19.58 per share 2,873,482.48
Jul 17, 2024 Jennifer Saenz EVP Pharmacy & eCommerce N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2024 Jennifer Saenz EVP Pharmacy & eCommerce 174,379 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 16, 2024 Kim S. Fennebresque Director 6,761 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 16, 2024 Chan W. Galbato Director 6,761 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Sharon L. McCollam President & CFO 119,414 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Michael T. Theilmann EVP & Chief HR Officer 56,406 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Michael T. Theilmann EVP & Chief HR Officer 37,506 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Michael T. Theilmann EVP & Chief HR Officer 15,049 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Michael T. Theilmann EVP & Chief HR Officer 56,994 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 James L. Donald Director 6,761 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Sharon L. Allen Director 6,761 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Thomas M. Moriarty EVP General Counsel & CPO 54,460 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Sharon L. McCollam President & CFO 95,689 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Sharon L. McCollam President & CFO 78,583 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Sharon L. McCollam President & CFO 31,679 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Thomas M. Moriarty EVP General Counsel & CPO 87,744 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Mary Elizabeth Stone West Director 6,761 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Alan H. Schumacher Director 6,761 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Sarah Mensah Director 6,761 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Albertsons Companies in the News

Markets

Kroger-Albertsons merger heads to trial

The FTC lawsuit to block the Albertsons-Kroger merger went to trial on Monday, with the agency arguing the deal undermines competition and the companies saying it will help consumers.

Lifestyle

Kroger-Albertsons merger in jeopardy

The Federal Trade Commission is suing to block Kroger's proposed $24.6 billion deal to buy a major rival, saying it would lead to higher prices for millions of Americans.